Atlas Trials

Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function

Clinical trial NCT04530383 · RECRUITING

Trial details

NCT number
NCT04530383
Sponsor
University of Kansas Medical Center
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis-related DiabetesCystic Fibrosis
Start date
2022-02-14
Primary completion
2027-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.